Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson To Host Enterprise Business Review Transcript

Dec 05, 2023 / 03:00PM GMT
Release Date Price: R$52.03 (-0.54%)
Operator

Ladies and gentlemen, at this time, we ask that you please turn all cell phones and electronic devices on silent. And please note that recordings, photography and screenshots of any kind are prohibited throughout the program. Thank you.

Welcome to the Johnson & Johnson 2023 Enterprise Business Review Meeting. Please note that today's presentation includes forward-looking statements and non-GAAP financial measures. We encourage you to review the cautionary statement included in today's presentation, which identifies certain factors that may cause the company's actual results to differ materially from those projected. These factors are described in our SEC filings, which are available at investor.jnj.com in addition to reconciliations of any non-GAAP financial measures used in today's presentation.

Additionally, several of the products and compounds discussed today are being developed in collaboration with strategic partners or licensed from other companies. These slides acknowledge those relationships.

(presentation)

Operator

Ladies and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot